-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明，无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
What Is Going on With Lava Therapeutics (LVTX) Stock Today?
What Is Going on With Lava Therapeutics (LVTX) Stock Today?
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Lava Therapeutics (NASDAQ:LVTX) stock is rocketing higher on Monday as investors react to news of an exclusive global license agreement with Seagen(NASDAQ:SGEN).
This agreement has Seagen agreeing to develop, manufacture and commercialize LAVA-1223. This is an advanced preclinical asset that makes use of Lava Therapeutics' proprietary Gammabody technology. This allows it to target epidermal growth factor receptor (EGFR)-expressing solid tumors.
That agreement has Seagen making an upfront payment of $50 million to Laval Therapeutics. It also includes up to $650 million in payments from development, regulatory and commercial milestones.
To go along with that, Seagen will also be paying Lava Therapeutics royalties on sales of the drug. The royalty rate ranges from single digits to the mid-teens.
LTVX's CEO Comments on the Agreement
Stephen Hurly, president and CEO of Lava Therapeutics, said the following about the deal.
"This agreement enables LAVA to further validate its platform in a second solid tumor product candidate, bringing us closer toward our goal of generating effective Gammabody medicines for cancer patients. We look forward to working with Seagen to develop potential next generation cancer treatments."
Today's news has shares of LVTX stock seeing heavy trading. As of this writing, over 23 million shares have changed hands. That's well above its daily average trading volume of only around 5,600 shares.
LVTX stock is up 100.1% as of Monday morning but is still down 22.1% year-to-date.
There's more stock market news traders will want to know about below!
We've got all of the latest stock market coverage investors need to know about on Monday! A few examples include the news moving shares of XPeng (NYSE:XPEV) and Bed Bath & Beyond (NASDAQ:BBBY) stock, as well as short squeeze targets for the week. You can get up to speed on all of that at the following links!
More Monday Stock Market News
- CEO He Xiaopeng Just Doubled Down on XPEV Stock. Here's Why.
- Dear BBBY Stock Fans, Mark Your Calendars for Sept. 29
- NERV, FAZE: The Top 5 Short Squeeze Stocks This Week
On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.
The post What Is Going on With Lava Therapeutics (LVTX) Stock Today? appeared first on InvestorPlace.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
InvestorPlace-股票市场新闻、股票建议和交易提示
Lava Therapeutics (NASDAQ:LVTX) stock is rocketing higher on Monday as investors react to news of an exclusive global license agreement with Seagen(NASDAQ:SGEN).
熔岩治疗学(纳斯达克：LVTX)周一，随着投资者对独家全球许可协议的消息做出反应，股价飙升海洋发电公司(纳斯达克：Sgen)。
This agreement has Seagen agreeing to develop, manufacture and commercialize LAVA-1223. This is an advanced preclinical asset that makes use of Lava Therapeutics' proprietary Gammabody technology. This allows it to target epidermal growth factor receptor (EGFR)-expressing solid tumors.
根据这项协议，西根同意开发、制造和商业化熔岩-1223。这是一项先进的临床前资产，利用了Lava治疗公司的专有Gammabody技术。这使得它可以靶向表达表皮生长因子受体(EGFR)的实体肿瘤。
That agreement has Seagen making an upfront payment of $50 million to Laval Therapeutics. It also includes up to $650 million in payments from development, regulatory and commercial milestones.
根据该协议，西根向拉瓦尔治疗公司预付了5000万美元。它还包括来自开发、监管和商业里程碑的高达6.5亿美元的付款。
To go along with that, Seagen will also be paying Lava Therapeutics royalties on sales of the drug. The royalty rate ranges from single digits to the mid-teens.
此外，Seagen还将支付Lava Treateutics销售该药物的特许权使用费。专利使用费的范围从个位数到十几岁左右。
LTVX's CEO Comments on the Agreement
LTVX首席执行官对该协议的评论
Stephen Hurly, president and CEO of Lava Therapeutics, said the following about the deal.
熔岩治疗公司首席执行官兼首席执行官总裁对这笔交易说了以下几句话。
"This agreement enables LAVA to further validate its platform in a second solid tumor product candidate, bringing us closer toward our goal of generating effective Gammabody medicines for cancer patients. We look forward to working with Seagen to develop potential next generation cancer treatments."
这项协议使LAVA能够在第二种固体肿瘤候选产品中进一步验证其平台，使我们离为癌症患者生产有效的Gammabody药物的目标更近了一步。我们期待着与Seagen合作开发潜在的下一代癌症治疗方法。
Today's news has shares of LVTX stock seeing heavy trading. As of this writing, over 23 million shares have changed hands. That's well above its daily average trading volume of only around 5,600 shares.
今天的新闻让LVTX的股票出现了大量的交易。截至撰写本文时，已有2300多万股易手。这远高于其仅约5,600股的日均成交量。
LVTX stock is up 100.1% as of Monday morning but is still down 22.1% year-to-date.
截至周一上午，伦敦证交所的股价上涨了100.1%，但今年迄今仍下跌了22.1%。
There's more stock market news traders will want to know about below!
下面还有更多的股市消息交易员想知道的！
We've got all of the latest stock market coverage investors need to know about on Monday! A few examples include the news moving shares of XPeng (NYSE:XPEV) and Bed Bath & Beyond (NASDAQ:BBBY) stock, as well as short squeeze targets for the week. You can get up to speed on all of that at the following links!
我们已经掌握了投资者周一需要了解的所有最新股市报道！一些例子包括移动股票的消息小鹏汽车*(纽约证券交易所：XPEV)和床浴及更上一层楼(纳斯达克：BBBY)股票，以及本周的空头挤压目标。你可以在下面的链接上获得所有这些东西的最新进展！
More Monday Stock Market News
更多周一股市新闻
- CEO He Xiaopeng Just Doubled Down on XPEV Stock. Here's Why.
- Dear BBBY Stock Fans, Mark Your Calendars for Sept. 29
- NERV, FAZE: The Top 5 Short Squeeze Stocks This Week
- 首席执行官何小鹏刚刚在XPEV股票上加倍下注。这就是为什么。
- 亲爱的BBY股票粉丝们，在你们的日历上标上9月1日的名字。29
- NERV，FUZE：本周五大做空股票
On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.
在出版日期，威廉·怀特他没有(直接或间接)持有本文所述证券的任何头寸。本文表达的观点是作者的观点，以InvestorPlace.com为准。出版指南。
The post What Is Going on With Lava Therapeutics (LVTX) Stock Today? appeared first on InvestorPlace.
帖子今天Lava治疗公司(LVTX)的股票怎么了？最先出现在InvestorPlace上。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国，moomoo上的投资产品和服务由Moomoo Financial Inc.提供，一家受美国证券交易委员会（SEC）监管的持牌主体。 Moomoo Financial Inc.是金融业监管局（FINRA）和证券投资者保护公司（SIPC）的成员。
在新加坡，moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供，该公司受新加坡金融管理局（MAS）监管(牌照号码︰CMS101000) ，持有资本市场服务牌照 (CMS) ，持有财务顾问豁免（Exempt Financial Adviser）资质。本内容未经新加坡金融管理局的审查。
在澳大利亚，moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供，该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构（AFSL No. 224663）。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件，这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大，通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供，并受加拿大投资监管机构（CIRO）监管。
在马来西亚，moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供，该公司受马来西亚证券监督委员会（SC）监管(牌照号码︰eCMSL/A0397/2024) ，持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国，moomoo上的投资产品和服务由Moomoo Financial Inc.提供，一家受美国证券交易委员会（SEC）监管的持牌主体。 Moomoo Financial Inc.是金融业监管局（FINRA）和证券投资者保护公司（SIPC）的成员。
在新加坡，moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供，该公司受新加坡金融管理局（MAS）监管(牌照号码︰CMS101000) ，持有资本市场服务牌照 (CMS) ，持有财务顾问豁免（Exempt Financial Adviser）资质。本内容未经新加坡金融管理局的审查。
在澳大利亚，moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供，该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构（AFSL No. 224663）。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件，这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大，通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供，并受加拿大投资监管机构（CIRO）监管。
在马来西亚，moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供，该公司受马来西亚证券监督委员会（SC）监管(牌照号码︰eCMSL/A0397/2024) ，持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能，分享给你的好友吧